Considerations During Development of a Protein A-Based Antibody Purification Process

by Harish Iyer, Felicia Henderson, Eric Cunningham, James Welbb, John Hanson, Christopher Bork, and Lynn Conley, IDEC Pharmaceuticals Corporation Scale-up changes in an antibody purification process can increase final product purity, make the process more robust, and reduce processing time. This case study focuses on the initial purification step -- protein A chromatography -- and offers data collected from several years of process development work on many different antibodies.

Related Content:

Downstream ProcessingManufacturing, Separation and PurificationManufacturing, Process ChromatographyBioPharm International-01-01-2002

Near Infrared Spectroscopy as a Versatile PAT Tool for Continuous Downstream Bioprocessing

A Unified Approach for Scaling Bioprocess Unit Operations

Meeting Fill/Finish Challenges for COVID-19 Vaccines